Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma

The recent finding that MYC-driven cancers are sensitive to inhibition of the DNA damage response (DDR) pathway, prompted us to investigate the role of DDR pathway as therapeutic target in diffuse large B-cell lymphoma (DLBCL), which frequently overexpresses the MYC oncogene. In a preliminary immuno...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Derenzini, Enrico, Agostinelli, Claudio, Imbrogno, Enrica, Iacobucci, Ilaria, Casadei, Beatrice, Brighenti, Elisa, Righi, Simona, Fuligni, Fabio, Di Rorà, Andrea Ghelli Luserna, Ferrari, Anna, Martinelli, Giovanni, Pileri, Stefano, Zinzani, Pier Luigi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2015
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4466634/
https://ncbi.nlm.nih.gov/pubmed/25544753
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg